scispace - formally typeset
A

Arianna Carolina Rosa

Researcher at University of Turin

Publications -  44
Citations -  1354

Arianna Carolina Rosa is an academic researcher from University of Turin. The author has contributed to research in topics: Histamine & Receptor. The author has an hindex of 16, co-authored 41 publications receiving 1110 citations. Previous affiliations of Arianna Carolina Rosa include Durham University & University of Florence.

Papers
More filters
Journal ArticleDOI

Histamine receptor expression in human renal tubules: a comparative pharmacological evaluation

TL;DR: All four histamine receptors in human renal tubules are identified, particularly the H4R, which was partially suppressed by the selective H2R, H3R and H 4R antagonists when each added alone, and completely ablated when combined together.
Journal ArticleDOI

Effects of amine oxidases in allergic and histamine-mediated conditions.

TL;DR: This review provides an update on histamine, on diamine oxidase (DAO) and on their implications in allergy and various conditions or affections, such as food histaminosis, ischemia and inflammatory bowel diseases (IBD).
Journal ArticleDOI

Histamine H4 receptor antagonism prevents the progression of diabetic nephropathy in male DBA2/J mice

TL;DR: The data suggest that the H4R participates in diabetic nephropathy progression through both a direct effect on tubular reabsorption and an indirect action on renal tissue architecture via inflammatory cell recruitment, and H 4R antagonism emerges as a possible new multi‐mechanism therapeutic approach to counteract development of diabetic neephropathy development.
Journal ArticleDOI

Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.

TL;DR: This work investigated the ability of natural and synthetic selective NK receptors agonists and antagonists to modulate cyclooxygenase‐2 (COX‐2) expression in human polymorphonuclear leucocytes (PMNs).
Journal ArticleDOI

Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis

TL;DR: The results here reported clearly demonstrated that H4R ligands have a beneficial effect in a model of lung fibrosis in the mouse, thus indicating that H 4R antagonists or inverse agonists could be a novel therapeutic strategy for lung inflammatory diseases.